Skip to main content
Equibles
RLMD logo

RLMD · Relmada Therapeutics, Inc. · Investor Relations

Track RLMD — free

Use RLMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RLMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.76 -0.02 (-0.40%)
Russell 2000 member Rebalance outlook locked
Market Cap
$408.55M
Shares
106.67M
Volume · Oct 1 374.97K Avg daily vol (3M) 1.36M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-08-06 Q2 2026 Financial Results Conference Call Earnings call
2026-07-04 Jefferies Global Healthcare Conference Conference
2026-06-04 Jefferies Global Healthcare Conference Conference
2026-05-27 2026 Annual Meeting of Stockholders Shareholder meeting
2026-05-18 American Urology Association (AUA2026) Event
2026-05-15 American Urology Association (AUA2026) Event
2026-05-12 Earnings conference call (announced in 8-K) Earnings call
2026-03-19 Q4 Earnings conference call (announced in 8-K) Earnings call
2026-03-10 Leerink Partners Global Healthcare Conference Conference
2025-12-04 Society of Urologic Oncology 26th Annual Meeting Shareholder meeting
2025-11-13 Q3 2025 Financial Results Conference Call Earnings call
2025-08-07 Q2 2025 Financial Results Conference Call Earnings call

Source: https://ir.relmada.com/

Key facts CIK 1553643 CUSIP 75955J402 13F (30d) 3 filings 3 filers Visit website Investor relations